SCHEMBL20072486

SCHEMBL20072486

C=C(Nc1ccccn1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 7/20 0.75
TRPV1 Q8NER1 5/20 0.50
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
DEGS1 O15121 2/20 0.45
AKR1C3 P42330 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
NAMPT P43490 1/20 0.43
DRD2 P14416 1/20 0.43
ADRA1A P35348 1/20 0.43
DRD3 P35462 1/20 0.43
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
BACE1 P56817 1/20 0.43
RAB9A P51151 1/20 0.43
CACNA1B Q00975 1/20 0.43
APBA1 Q02410 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20063108 0.86 PHGDH (1.00) PHGDHRAB9ACACNA1BAPBA1KMT2A
SCHEMBL20072512 0.74 PHGDH (0.59) PHGDHRAB9ACACNA1BAPBA1KMT2A
SCHEMBL20072632 0.74 PHGDH (0.60) PHGDHRAB9ACACNA1BAPBA1KMT2A
SCHEMBL20063114 0.74 PHGDH (1.00) PHGDHRAB9ACACNA1BAPBA1KMT2A
SCHEMBL10365728 0.72 CA12 (0.62) PHGDHCA12CA2CA9AKR1C3
SCHEMBL13931350 0.71 TRPV1 (0.61) TRPV1TRPM8
SCHEMBL4722493 0.70 SMN1; SMN2 (0.54) PHGDHCA12CA2CA9AKR1C3
SCHEMBL20072474 0.69 PHGDH (0.80) PHGDHRAB9ACACNA1BAPBA1KMT2A
SCHEMBL20063094 0.69 PHGDH (1.00) PHGDHRAB9ACACNA1BAPBA1KMT2A
SCHEMBL28650484 0.69 CA12 (0.65) PHGDHCA12CA2CA9AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-01-18 US disclosed
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof PHGDH, PGD, PGK1 PHGDH 1/4885TRPV1 2195/4885CA12 1176/4885
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF PHGDH, PGD, PGK1 PHGDH 1/4885TRPV1 2046/4885CA12 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.